Skip to main content
Premium Trial:

Request an Annual Quote

Hibergene Closes €6.7M Series B Funding Round

NEW YORK (GenomeWeb) – Molecular diagnostics maker Hibergene has closed a Series B funding round of €6.7 million ($7.2 million), the company announced today. The new funds will expand the firm's research and development programs and its international distributor network.

The Series B round was led by Cantor Fitzgerald and included Kernel Capital through the Bank of Ireland Kernel Capital Venture Funds and MedCaptain, Hibergene's distributor for China. Enterprise Investment Scheme (EIS) investment in the UK was advised by Ruffena Capital Ltd resulting in UK-based investors subscribing for shares through the SyndicateRoom investment platform, the firm said.

Hibergene has launched five products in the infectious disease diagnostics space to date that use loop-mediated isothermal amplification (LAMP): tests for meningococcal meningitis, Clostridium difficile, two assays for Group B Strep, as well as its HG Swift platform. The firm plans to launch more diagnostic tests in 2017, including ones for Mycoplasma pneumoniae, influenza A and B, and respiratory syncytial viruses 1 and 2. 

The company currently has 24 distributors covering 36 countries, across Europe, Asia, the Middle East and Africa, and this will be expanded to cover additional territories, including North and South America.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.